| Product Number : |
CL1332 |
| Product Name : |
Alpelisib |
| CAS No. : |
1217486-61-7 |
| Synonyms : |
BYL-719 |
| Chemical Name : |
|
| Molecular Formula : |
C19H22F3N5O2S |
| Molecular Weight : |
441.47 |
| Molecular Structure : |
 |
| Appearance : |
Off-white to light yellow powder |
| Specification : |
98+% |
| Application : |
|
| Registration : |
|
| Storage Condition : |
Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kα inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.
